Overview

A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, 3 arm, placebo-controlled clinical trial to assess the efficacy, safety and tolerability of pagoclone for adults with stuttering.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Collaborator:
Teva Pharmaceuticals USA